Substance / Medication

D-alpha-tocopherol

Overview

Active Ingredient
alpha tocopherol
RxNorm CUI
237099

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
IL-8 production and AP-1 transactivation induced by UVA in human keratinocytes: roles of D-alpha-tocopherol.
Wu Shuling, Gao Jianping, Dinh Q Thai et al. · Mol Immunol · 2008
PMID: 18206243Other
Spectroscopic studies of D-alpha-tocopherol concentration-induced transformation in egg phosphatidylcholine vesicles.
Dwiecki Krzysztof, Górnas Paweł, Wilk Agnieszka et al. · Cell Mol Biol Lett · 2007
PMID: 17124545OtherFull text (PMC)
Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.
Prashant Chandrasekharan, Dipak Maity, Yang Chang-Tong et al. · Biomaterials · 2010
PMID: 20434210Preclinical
Ultraviolet B-induced DNA damage in human epidermis is modified by the antioxidants ascorbic acid and D-alpha-tocopherol.
Placzek Marianne, Gaube Sabine, Kerkmann Urs et al. · J Invest Dermatol · 2005
PMID: 15675947Trial
Effect of D-alpha-tocopherol on tubular nephron acidification by rats with induced diabetes mellitus.
Nascimento Gomes G, Barbosa F T, Radaeli R F et al. · Braz J Med Biol Res · 2005
PMID: 16007275Preclinical
Peroxidative protection of parenteral admixture by D-alpha-tocopherol.
Becvarova Iveta, Saker Korinn E, Swecker William S et al. · Vet Ther · 2005
PMID: 16550490Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
D-alpha-tocopherol (substance)
SNOMED CT
116776001
UMLS CUI
C0969677
RxNorm CUI
237099

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.